These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1335684)

  • 1. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancers: the role of local immunosurveillance.
    Majewski S; Jablonska S
    Am J Med Sci; 1992 Sep; 304(3):174-9. PubMed ID: 1335684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin.
    Majewski S; Jabłońska S
    Arch Dermatol; 1995 Nov; 131(11):1312-8. PubMed ID: 7503577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses.
    Orth G
    Semin Immunol; 2006 Dec; 18(6):362-74. PubMed ID: 17011789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis.
    Majewski S; Malejczyk J; Jablonska S; Misiewicz J; Rudnicka L; Obalek S; Orth G
    J Am Acad Dermatol; 1990 Mar; 22(3):423-7. PubMed ID: 2155952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. The Nambour Skin Cancer Prevention Study Group.
    Boxman IL; Russell A; Mulder LH; Bavinck JN; Schegget JT; Green A
    Int J Cancer; 2000 Apr; 86(1):118-21. PubMed ID: 10728604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mouse model for studying epidermodysplasia-verruciformis-associated carcinogenesis.
    Majewski S; Breitburd F; Skopinska M; Croissant O; Jablonska S; Orth G
    Int J Cancer; 1994 Mar; 56(5):727-30. PubMed ID: 8314350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomaviruses and skin cancer.
    Pfister H
    Semin Cancer Biol; 1992 Oct; 3(5):263-71. PubMed ID: 1335790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency in
    Torres AD; King RE; Uberoi A; Buehler D; Yoshida S; Ward-Shaw E; Lambert PF
    J Virol; 2024 Jul; 98(7):e0017424. PubMed ID: 38869286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic potential of human papillomaviruses epidermodysplasia verruciformis: a counterpart of Shope papilloma-carcinoma complex.
    Jabłonska S; Orth G; Obalek S; Croissant O; Jarzabek-Chorzelska M; Favre M; Kremsdorf D
    Arch Geschwulstforsch; 1983; 53(3):207-15. PubMed ID: 6311135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus type 38 isolated from patients with epidermodysplasia verruciformis.
    Yutsudo M; Kanda R; Tanigaki T; Kitano Y; Hakura A
    Intervirology; 1986; 26(1-2):104-8. PubMed ID: 3032841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermodysplasia verruciformis.
    Burger B; Itin PH
    Curr Probl Dermatol; 2014; 45():123-31. PubMed ID: 24643182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations?
    Majewski S; Jablonska S
    Arch Dermatol; 2002 May; 138(5):649-54. PubMed ID: 12020228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis.
    Padlewska K; Ramoz N; Cassonnet P; Riou G; Barrois M; Majewski S; Croissant O; Jablonska S; Orth G
    J Invest Dermatol; 2001 Oct; 117(4):935-42. PubMed ID: 11676835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermodysplasia verruciformis: a model for understanding the oncogenicity of human papillomaviruses.
    Orth G
    Ciba Found Symp; 1986; 120():157-74. PubMed ID: 3013521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin autografts in epidermodysplasia verruciformis: human papillomavirus-associated cutaneous changes need over 20 years for malignant conversion.
    Majewski S; Jablonska S
    Cancer Res; 1997 Oct; 57(19):4214-6. PubMed ID: 9331078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Papillomavirus and cancer].
    Hakura A
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2011-21. PubMed ID: 2840032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA.
    Weissenborn SJ; Höpfl R; Weber F; Smola H; Pfister HJ; Fuchs PG
    J Invest Dermatol; 1999 Jul; 113(1):122-6. PubMed ID: 10417630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis of human papillomavirus infection in patients with epidermodysplasia verruciformis].
    Liang S; Zuo YG; Wang BX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):93-6. PubMed ID: 19317070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses.
    Lutzner MA; Blanchet-Bardon C; Orth G
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):18s-25s. PubMed ID: 6330217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of human papillomavirus type 20 in epidermodysplasia verruciformis skin carcinogenesis.
    Yutsudo M; Tanigaki T; Kanda R; Sasagawa T; Inoue T; Jing P; Yong-Il H; Hakura A
    J Clin Microbiol; 1994 Apr; 32(4):1076-8. PubMed ID: 8027315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.